Schonfeld Strategic Advisors LLC Verona Pharma PLC Transaction History

Schonfeld Strategic Advisors LLC

  • $12.5 Billion
  • Q2 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 42,950 shares of VRNA stock, worth $4.59 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
42,950
Previous 11,473 274.36%
Holding current value
$4.59 Million
Previous $728,000 457.97%
% of portfolio
0.03%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$53.9 - $98.68 $1.7 Million - $3.11 Million
31,477 Added 274.36%
42,950 $4.06 Million
Q1 2025

May 15, 2025
SELL
$44.81 - $69.63 $3.04 Million - $4.73 Million
-67,927 Reduced 85.55%
11,473 $728,000
Q4 2024

Feb 14, 2025
BUY
$28.71 - $47.02 $1.69 Million - $2.77 Million
58,978 Added 288.8%
79,400 $3.69 Million
Q3 2024

Nov 14, 2024
SELL
$15.46 - $30.16 $3.12 Million - $6.08 Million
-201,574 Reduced 90.8%
20,422 $587,000
Q2 2024

Aug 14, 2024
SELL
$11.48 - $17.02 $438,581 - $650,232
-38,204 Reduced 14.68%
221,996 $3.21 Million
Q1 2024

May 15, 2024
SELL
$15.3 - $20.24 $639,540 - $846,031
-41,800 Reduced 13.84%
260,200 $4.19 Million
Q4 2023

Feb 14, 2024
BUY
$11.94 - $20.47 $1.33 Million - $2.28 Million
111,594 Added 58.61%
302,000 $6 Million
Q3 2023

Nov 14, 2023
SELL
$16.3 - $22.09 $40,929 - $55,467
-2,511 Reduced 1.3%
190,406 $3.1 Million
Q2 2023

Aug 14, 2023
SELL
$19.41 - $23.43 $2.77 Million - $3.35 Million
-142,783 Reduced 42.53%
192,917 $4.08 Million
Q1 2023

May 15, 2023
SELL
$18.06 - $25.27 $1.52 Million - $2.13 Million
-84,097 Reduced 20.03%
335,700 $6.74 Million
Q4 2022

Feb 14, 2023
BUY
$9.84 - $26.13 $3.55 Million - $9.43 Million
360,797 Added 611.52%
419,797 $11 Million
Q3 2022

Nov 14, 2022
BUY
$4.14 - $13.59 $19,458 - $63,873
4,700 Added 8.66%
59,000 $603,000
Q2 2022

Aug 15, 2022
SELL
$3.55 - $5.06 $14,555 - $20,746
-4,100 Reduced 7.02%
54,300 $227,000
Q1 2022

May 16, 2022
BUY
$4.82 - $6.98 $1,928 - $2,792
400 Added 0.69%
58,400 $292,000
Q4 2021

Feb 14, 2022
SELL
$3.91 - $7.08 $2,346 - $4,248
-600 Reduced 1.02%
58,000 $390,000
Q3 2021

Nov 16, 2021
BUY
$5.29 - $6.35 $2,116 - $2,540
400 Added 0.69%
58,600 $321,000
Q2 2021

Aug 16, 2021
BUY
$5.72 - $9.09 $9,724 - $15,453
1,700 Added 3.01%
58,200 $381,000
Q1 2021

May 17, 2021
BUY
$7.08 - $9.33 $61,596 - $81,171
8,700 Added 18.2%
56,500 $472,000
Q4 2020

Feb 16, 2021
SELL
$5.51 - $8.11 $37,468 - $55,147
-6,800 Reduced 12.45%
47,800 $334,000
Q3 2020

Nov 16, 2020
BUY
$4.45 - $10.2 $242,970 - $556,920
54,600 New
54,600 $0

Others Institutions Holding VRNA

# of Institutions
322
Shares Held
76.8M
Call Options Held
977K
Put Options Held
3.12M
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.51B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email